指南与共识消化道肿瘤与早癌消化内镜

BSG/ACPGBI/UKCGG 遗传性结直肠癌管理指南

Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).
指南 / 共识 · Gut · 2019-11-28

该指南由英国胃肠病学会、英国结直肠病协会和英国癌症遗传学组联合制定,基于对10 189篇文献的系统综述,针对遗传因素导致结直肠癌风险升高的人群(包括Lynch综合征、息肉病或结直肠癌家族史者),提出了67条基于证据和专家意见的推荐,并列出10条研究建议。

要点

  • 遗传因素约占结直肠癌风险的35%,英国近30%人口有结直肠癌家族史。
  • 指南针对Lynch综合征、息肉病或结直肠癌家族史等遗传高风险人群。
  • 推荐涉及内镜监测、预防性手术和化学预防等降低风险干预措施。

核心结论

  • 指南为遗传性结直肠癌风险人群的管理提供了67条基于证据和专家意见的推荐。

研究设计与样本

  • 由BSG、ACPGBI和UKCGG联合制定,采用Delphi流程进行外部评审,基于对10 189篇出版物的系统综述。

主要发现

  • 遗传因素约占结直肠癌风险的35%,英国近30%人口有结直肠癌家族史。
  • 指南针对Lynch综合征、息肉病或结直肠癌家族史等遗传高风险人群。

关键数值与推荐

  • 提出了67条基于证据和专家意见的推荐用于遗传性结直肠癌风险管理。
  • 列出了10条优先研究建议以指导临床管理。

临床怎么用

  • 通过准确表型评估和遗传诊断量化个体终生胃肠道癌症风险,以指导内镜监测、预防性手术和化学预防等干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heritable factors account for approximately 35% of colorectal cancer (CRC) risk, and almost 30% of the population in the UK have a family history of CRC. The quantification of an individual's lifetime risk of gastrointestinal cancer may incorporate clinical and molecular data, and depends on accurate phenotypic assessment and genetic diagnosis. In turn this may facilitate targeted risk-reducing interventions, including endoscopic surveillance, preventative surgery and chemoprophylaxis, which provide opportunities for cancer prevention. This guideline is an update from the 2010 British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland (BSG/ACPGBI) guidelines for colorectal screening and surveillance in moderate and high-risk groups; however, this guideline is concerned specifically with people who have increased lifetime risk of CRC due to hereditary factors, including those with Lynch syndrome, polyposis or a family history of CRC. On this occasion we invited the UK Cancer Genetics Group (UKCGG), a subgroup within the British Society of Genetic Medicine (BSGM), as a partner to BSG and ACPGBI in the multidisciplinary guideline development process. We also invited external review through the Delphi process by members of the public as well as the steering committees of the European Hereditary Tumour Group (EHTG) and the European Society of Gastrointestinal Endoscopy (ESGE). A systematic review of 10 189 publications was undertaken to develop 67 evidence and expert opinion-based recommendations for the management of hereditary CRC risk. Ten research recommendations are also prioritised to inform clinical management of people at hereditary CRC risk.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Monahan KJ, Bradshaw N, Dolwani S, et al. Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG). Gut. 2019. PMID: 31780574. doi:10.1136/gutjnl-2019-319915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。